Reagenzien und Instrumente für die Immunologie Zellbiologie und Molekularbiologie
 

MyBiosource

  Alle Produkte
 
Website: 
http://ibiologics.com
 
SARS-CoV-2 - Duvelisib - Therapeutic Candidates

SARS-CoV-2 - Duvelisib - Therapeutic Candidates

Ergebnis Ihrer Suche : 20 Produkt(e) gefunden

Grenzen Sie Ihre Suche ein :

RUOCE / IVD
  • Unconjugated 12
  • Biochemicals 11
  • Inhibitor/Antagonist/Agonist 9
FILTER ANWENDEN
REINITIALISIEREN


Katalog-Nummer
Beschreibung
Cond.
Preis zzgl. MwSt.
MBS3600723-5x100mg
Duvelisib
 5x100mg 
MBS3600723-100mg
Duvelisib
 100mg 
MBS3600723-2mg
Duvelisib
 2mg 
MBS3600723-50mg
Duvelisib
 50mg 
MBS3600723-10mg
Duvelisib
 10mg 
MBS3600723-25mg
Duvelisib
 25mg 
MBS3600723-5mg
Duvelisib
 5mg 
MBS5753059-5x1mg
Duvelisib R enantiomer
 5x1mg 
MBS5753059
Duvelisib R enantiomer
 Onrequest 
MBS575674
Duvelisib (IPI-145, INK1197)
 Onrequest 
MBS384926-25mg
IPI-145 (Duvelisib, INK1197)
 25mg 
MBS384926-50mg
IPI-145 (Duvelisib, INK1197)
 50mg 
MBS384926-5x50mg
IPI-145 (Duvelisib, INK1197)
 5x50mg 
MBS384926-5mg
IPI-145 (Duvelisib, INK1197)
 5mg 
MBS384926-10mg
IPI-145 (Duvelisib, INK1197)
 10mg 
MBS384926-1mL
IPI-145 (Duvelisib, INK1197)
 1mL(inDMSO) 
MBS3614832-10mg
Duvelisib(R enantiomer)
 10mg 
MBS3614832-50mg
Duvelisib(R enantiomer)
 50mg 
MBS3614832-100mg
Duvelisib(R enantiomer)
 100mg 
MBS3614832-5x100mg
Duvelisib(R enantiomer)
 5x100mg 
    ‹
    ›